Cargando…
A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system
Based on the recent reports, cardiovascular events encompass a large portion of the mortality caused by the COVID‐19 pandemic, which drawn cardiologists into the management of the admitted ill patients. Given that common laboratory values may provide key insights into the illness caused by the life‐...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743667/ https://www.ncbi.nlm.nih.gov/pubmed/34894069 http://dx.doi.org/10.1111/jcmm.17122 |
_version_ | 1784629955262414848 |
---|---|
author | Rezabakhsh, Aysa Sadat‐Ebrahimi, Seyyed‐Reza Ala, Alireza Nabavi, Seyed Mohammad Banach, Maciej Ghaffari, Samad |
author_facet | Rezabakhsh, Aysa Sadat‐Ebrahimi, Seyyed‐Reza Ala, Alireza Nabavi, Seyed Mohammad Banach, Maciej Ghaffari, Samad |
author_sort | Rezabakhsh, Aysa |
collection | PubMed |
description | Based on the recent reports, cardiovascular events encompass a large portion of the mortality caused by the COVID‐19 pandemic, which drawn cardiologists into the management of the admitted ill patients. Given that common laboratory values may provide key insights into the illness caused by the life‐threatening SARS‐CoV‐2 virus, it would be more helpful for screening, clinical management and on‐time therapeutic strategies. Commensurate with these issues, this review article aimed to discuss the dynamic changes of the common laboratory parameters during COVID‐19 and their association with cardiovascular diseases. Besides, the values that changed in the early stage of the disease were considered and monitored during the recovery process. The time required for returning biomarkers to basal levels was also discussed. Finally, of particular interest, we tended to abridge the latest updates regarding the cardiovascular biomarkers as prognostic and diagnostic criteria to determine the severity of COVID‐19. |
format | Online Article Text |
id | pubmed-8743667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87436672022-01-12 A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system Rezabakhsh, Aysa Sadat‐Ebrahimi, Seyyed‐Reza Ala, Alireza Nabavi, Seyed Mohammad Banach, Maciej Ghaffari, Samad J Cell Mol Med Reviews Based on the recent reports, cardiovascular events encompass a large portion of the mortality caused by the COVID‐19 pandemic, which drawn cardiologists into the management of the admitted ill patients. Given that common laboratory values may provide key insights into the illness caused by the life‐threatening SARS‐CoV‐2 virus, it would be more helpful for screening, clinical management and on‐time therapeutic strategies. Commensurate with these issues, this review article aimed to discuss the dynamic changes of the common laboratory parameters during COVID‐19 and their association with cardiovascular diseases. Besides, the values that changed in the early stage of the disease were considered and monitored during the recovery process. The time required for returning biomarkers to basal levels was also discussed. Finally, of particular interest, we tended to abridge the latest updates regarding the cardiovascular biomarkers as prognostic and diagnostic criteria to determine the severity of COVID‐19. John Wiley and Sons Inc. 2021-12-11 2022-01 /pmc/articles/PMC8743667/ /pubmed/34894069 http://dx.doi.org/10.1111/jcmm.17122 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Rezabakhsh, Aysa Sadat‐Ebrahimi, Seyyed‐Reza Ala, Alireza Nabavi, Seyed Mohammad Banach, Maciej Ghaffari, Samad A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system |
title | A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system |
title_full | A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system |
title_fullStr | A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system |
title_full_unstemmed | A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system |
title_short | A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system |
title_sort | close‐up view of dynamic biomarkers in the setting of covid‐19: striking focus on cardiovascular system |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743667/ https://www.ncbi.nlm.nih.gov/pubmed/34894069 http://dx.doi.org/10.1111/jcmm.17122 |
work_keys_str_mv | AT rezabakhshaysa acloseupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT sadatebrahimiseyyedreza acloseupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT alaalireza acloseupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT nabaviseyedmohammad acloseupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT banachmaciej acloseupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT ghaffarisamad acloseupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT rezabakhshaysa closeupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT sadatebrahimiseyyedreza closeupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT alaalireza closeupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT nabaviseyedmohammad closeupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT banachmaciej closeupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem AT ghaffarisamad closeupviewofdynamicbiomarkersinthesettingofcovid19strikingfocusoncardiovascularsystem |